文献速递认知障碍与痴呆

全糖蛋白质组发现可能为老年人提供认知韧性的皮层糖蛋白

Glycoproteome-Wide Discovery of Cortical Glycoproteins That May Provide Cognitive Resilience in Older Adults.
PubMed 文献 · Neurology · 2024-03-19

BACKGROUND AND OBJECTIVES: Molecular omics studies have identified proteins related to cognitive resilience but unrelated to Alzheimer disease and Alzheimer disease-related dementia (AD/ADRD) pathologies.…

要点

  • 在366例老年人脑组织中,8种糖肽形式与认知下降相关且独立于AD/ADRD病理。
  • 糖基化来源的4种糖肽形式水平较高与较慢认知下降相关,糖化来源的4种与较快下降相关。
  • 这8种糖肽形式合计解释额外6%的认知下降变异,作者认为靶向这些糖肽形式可能带来维持认知的疗法。

核心结论

  • 衰老大脑中的糖肽形式可能提供认知韧性,靶向这些糖肽形式可能带来通过韧性维持认知的疗法(作者结论)。

研究设计与样本

  • 研究纳入366例接受年度认知测试的成人脑组织,死亡时平均年龄89岁,70%为女性,认知状态:无认知障碍152例,轻度认知障碍93例,阿尔茨海默病121例。

主要发现

  • 在校正年龄、性别和教育的模型中,11种糖肽形式与认知下降相关。
  • 进一步校正AD/ADRD病理后,8种糖肽形式仍与认知下降相关:NPTX2a(估计值0.030,标准误0.005,p = 1 × 10-4)、NPTX2b(估计值0.019,标准误0.005,p = 2 × 10-4)、NECTIN1(估计值0.029,标准误0.009,p = 9 × 10-4)、NPTX2c(估计值0.015,标准误0.004,p = 9 × 10-4)、HSPB1(估计值-0.021,标准误0.006,p = 2 × 10-4)、PLTP(估计值-0.027,标准误0.009,p = 4.2 × 10-3)、NAGK(估计值-0.027,标准误0.008,p = 1.4 × 10-3)和VAT1(估计值-0.020,标准误0.006,p = 1.1 × 10-3)。
  • 通过糖基化衍生的4种韧性糖肽形式水平较高与较慢下降相关,通过糖化衍生的4种水平较高与较快下降相关。
  • 这8种糖肽形式合计额外解释6%的认知下降变异,而10种脑病理和人口学特征解释33%。
  • 校正相应蛋白质表达水平后,所有8种韧性糖肽形式仍与认知下降相关;探索性基因本体分析提示相关分子机制可能涉及丙酮酸和NADH通路等代谢通路,并强调葡萄糖代谢相关分子机制的重要性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Molecular omics studies have identified proteins related to cognitive resilience but unrelated to Alzheimer disease and Alzheimer disease-related dementia (AD/ADRD) pathologies. Posttranslational modifications of proteins with glycans can modify protein function. In this study, we identified glycopeptiforms associated with cognitive resilience. METHODS: We studied brains from adults with annual cognitive testing with postmortem indices of 10 AD/ADRD pathologies and proteome-wide data from dorsal lateral prefrontal cortex (DLPFC). We quantified 11, 012 glycopeptiforms from DLPFC using liquid chromatography with tandem mass spectrometry. We used linear mixed-effects models to identify glycopeptiforms associated with cognitive decline correcting for multiple comparisons (p < 5 × 10-6). Then, we regressed out the effect of AD/ADRD pathologies to identify glycopeptiforms that may provide cognitive resilience. RESULTS: We studied 366 brains, average age at death 89 years, and 70% female with no cognitive impairment = 152, mild cognitive impairment = 93, and AD = 121 cognitive status at death. In models adjusting for age, sex and education, 11 glycopeptiforms were associated with cognitive decline. In further modeling, 8 of these glycopeptiforms remained associated with cognitive decline after adjusting for AD/ADRD pathologies: NPTX2a (Est., 0.030, SE, 0.005, p = 1 × 10-4); NPTX2b (Est.,0.019, SE, 0.005, p = 2 × 10-4) NECTIN1(Est., 0.029, SE, 0.009, p = 9 × 10-4), NPTX2c (Est., 0.015, SE, 0.004, p = 9 × 10-4), HSPB1 (Est., -0.021, SE, 0.006, p = 2 × 10-4), PLTP (Est., -0.027, SE, 0.009, p = 4.2 × 10-3), NAGK (Est., -0.027, SE, 0.008, p = 1.4 × 10-3), and VAT1 (Est., -0.020, SE, 0.006, p = 1.1 × 10-3). Higher levels of 4 resilience glycopeptiforms derived through glycosylation were associated with slower decline and higher levels of 4 derived through glycation were related to faster decline. Together, these 8 glycopeptiforms accounted for an additional 6% of cognitive decline over the 33% accounted for the 10 brain pathologies and demographics. All 8 resilience glycopeptiforms remained associated with cognitive decline after adjustments for the expression level of their corresponding protein. Exploratory gene ontology suggested that molecular mechanisms of glycopeptiforms associated with cognitive decline may involve metabolic pathways including pyruvate and NADH pathways and highlighted the importance of molecular mechanisms involved in glucose metabolism. DISCUSSION: Glycopeptiforms in aging brains may provide cognitive resilience. Targeting these glycopeptiforms may lead to therapies that maintain cognition through resilience.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Buchman AS, Yu L, Klein HU, et al. Glycoproteome-Wide Discovery of Cortical Glycoproteins That May Provide Cognitive Resilience in Older Adults. Neurology. 2024. PMID: 38502899. doi:10.1212/WNL.0000000000209223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。